Filter News
Area of Research
- (-) Nuclear Science and Technology (3)
- Biological Systems (1)
- Biology and Environment (27)
- Clean Energy (55)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (1)
- Fusion and Fission (5)
- Isotopes (4)
- Materials (56)
- Materials for Computing (4)
- National Security (3)
- Neutron Science (21)
- Supercomputing (23)
News Topics
- (-) Biomedical (1)
- (-) Physics (2)
- 3-D Printing/Advanced Manufacturing (4)
- Advanced Reactors (6)
- Bioenergy (1)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Fusion (7)
- Isotopes (4)
- Materials Science (3)
- Molten Salt (1)
- Neutron Science (2)
- Nuclear Energy (24)
- Space Exploration (3)
- Sustainable Energy (1)
- Transformational Challenge Reactor (3)
Media Contacts
As a teenager, Kat Royston had a lot of questions. Then an advanced-placement class in physics convinced her all the answers were out there.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.
After more than a year of operation at the Department of Energy’s (DOE’s) Oak Ridge National Laboratory (ORNL), the COHERENT experiment, using the world’s smallest neutrino detector, has found a big fingerprint of the elusive, electrically neutral particles that interact only weakly with matter.